Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations

Jacques De Greve, Erik Teugels, Caroline Geers, Johan De Mey, Pieter In 'T Veld, Lore Decoster, Martine Taton, Mehdi Shahidi, D. Galdermans, Denis Schallier

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Pages (from-to)555-556
Number of pages2
JournalEuropean Journal of Cancer. Supplement
Volume7
Issue numberSeptember
Publication statusPublished - 2009
EventUnknown -
Duration: 1 Jan 2009 → …

Keywords

  • adenocarcinoma
  • lung cancer
  • EGFR

Cite this